SYNH Live-Signale | Maximieren Sie Profite mit Getagraph.com

Live Chart Being Loaded With Signals

Commentary (27 Sep 2023 @ 22:00):

Syneos Health, Inc. provides biopharmaceutical outsourcing solutions company in North America, Europe, the Middle East, Africa, the Asia-Pacific, and Latin America...

Stats
Tagesvolumen	6.70M
Durchschnittsvolumen	1.32M
Marktkapitalisierung	4.46B
EPS	$0 ( 2024-02-14 )
Nächstes Ertragsdatum	( $0 ) 2024-05-08
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	61.40
ATR14	$0.108 (0.25%)

Insider Trading

Date	Person	Action	Amount	type
2023-09-28	Zulueta Alfonso G	Sell	3 493	Class A Common Stock
2023-09-28	Zulueta Alfonso G	Sell	4 863	Class A Common Stock
2023-09-28	Wilkes David S.	Sell	4 973	Class A Common Stock
2023-09-28	Wilkes David S.	Sell	4 863	Class A Common Stock
2023-09-28	Monaghan Matthew E.	Sell	19 777	Class A Common Stock

INSIDER POWER
-46.30
Last 97 transactions
Buy: 420 799 \| Sell: 674 760

Volumen Korrelation

Lang: -0.27 (neutral)

Kurz: 0.28 (neutral)

Signal:(72.61) Neutral

Syneos Health Inc Korrelation

10 Am meisten positiv korreliert
ISNS	0.919
GAINL	0.894
APOP	0.85
TDAC	0.844
SVOK	0.841
RMRM	0.828
PAIC	0.825
YMAB	0.822
HBNC	0.812

10 Am meisten negativ korreliert
BOCH	-0.943
SHSP	-0.903
MMAC	-0.836
NUVL	-0.836
QADA	-0.818
MCBC	-0.804
NETE	-0.804
TESS	-0.804

Wussten Sie das?

Korrelation ist ein statistisches Maß, das die Beziehung zwischen zwei Variablen beschreibt. Es reicht von -1 bis 1, wobei -1 eine perfekte negative Korrelation (wenn eine Variable zunimmt, nimmt die andere ab) anzeigt, 1 eine perfekte positive Korrelation (wenn eine Variable zunimmt, nimmt die andere zu) und 0 keine Korrelation anzeigt (es besteht kein Zusammenhang zwischen den Variablen).

Korrelation kann verwendet werden, um die Beziehung zwischen beliebigen zwei Variablen zu analysieren, nicht nur zwischen Aktien. Es wird häufig in Bereichen wie Finanzen, Wirtschaft, Psychologie und mehr verwendet.

Syneos Health Inc Korrelation - Währung/Rohstoff

-0.30
( neutral )

0.47
( neutral )

0.00
( neutral )

-0.33
( neutral )

0.35
( neutral )

Syneos Health Inc Finanzdaten

Annual	2022
Umsatz:	$5.39B
Bruttogewinn:	$1.25B (23.26 %)
EPS:	$2.57

FY	2022
Umsatz:	$5.39B
Bruttogewinn:	$1.25B (23.26 %)
EPS:	$2.57

FY	2021
Umsatz:	$5.21B
Bruttogewinn:	$1.22B (23.37 %)
EPS:	$2.26

FY	2020
Umsatz:	$4.42B
Bruttogewinn:	$1.02B (23.05 %)
EPS:	$1.850

Financial Reports:

No articles found.

Syneos Health Inc

Syneos Health, Inc. provides biopharmaceutical outsourcing solutions company in North America, Europe, the Middle East, Africa, the Asia-Pacific, and Latin America. It operates through two segments, Clinical Solutions and Commercial Solutions. The Clinical Solutions segment offers services for the development of diagnostics, drugs, biologics, devices, and digital therapeutics in the Phase I to IV of clinical development. This segment also provides individual services, including product development and regulatory consulting, project management, protocol development, investigational site recruitment, clinical monitoring, technology-enabled patient recruitment and engagement, clinical home health, clinical trial diversity, biometric, and regulatory affair services. The Commercial Solutions segment provides commercialization services, including deployment solutions, communications solutions, such as public relations, advertising, and medical communication services; and consulting services to the pharmaceutical, biotechnology, and healthcare industries. The company was formerly known as INC Research Holdings, Inc. and changed its name to Syneos Health, Inc. in January 2018. Syneos Health, Inc. was incorporated in 2010 and is headquartered in Morrisville, North Carolina.